Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2027

Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.

Patents
599

Quick answer

599 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7282205

    Anti-hepatitis A virus antibodies

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7285639

    Antibody to telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7285668

    Process for the crystallization of (R)- or (S)-lansoprazole

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7285556

    Thienopyrimidine-based inhibitors of the src family

    The Board of Regents of the University of Texas System · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7285542

    Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7285281

    Mutant forms of cholera holotoxin as an adjuvant

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7285683

    Bicyclic and tricyclic cannabinoids

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7285363

    Photoactivators, methods of use, and the articles derived therefrom

    UNIVERSITY OF CONNECTICUT · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7285564

    Substituted 4-amino-1-(pyridylmethyl)piperidine and related compounds

    Theravance, Inc. · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7285415

    Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury

    The Regents of the University of California · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7285534

    Corticotropin-releasing hormone analogs and their uses

    The Regents of the University of California · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7285527

    Tumor radiosensitization using gene therapy

    The Regents of the University of California · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7285383

    Method for selective inactivation of viral replication

    Rigel Pharmaceuticals, Inc. · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7285532

    Therapeutic method for treating bone formation diseases

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. EP 1847258

    Partialglyceride als Schmiermittel für pharmazeutische Zusammensetzungen enthaltend Thieno[3,2-c]pyridin-Derivate

    RENTSCHLER GMBH [DE] · Granted Wed Oct 24 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Oct 19 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7288254

    Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation

    The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7288654

    Fused-ring pyridine derivative, process for producing the same, and use

    Takeda Pharmaceutical Company Limited · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7288624

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7288671

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7288246

    Method of alleviating chronic pain via peripheral glutaminase regulation

    The Board of Regents of the University of Oklahoma · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7288266

    Liposome complexes for increased systemic delivery

    UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7288369

    Replication competent hepatitis C virus and methods of use

    The Board of Regents of the University of Texas System · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7288258

    Polyepitopic protein fragments of the E6 and E7 proteins of HPV, their production and their use particularly in vaccination

    Peptide Immune Ligands · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7288263

    Compositions and methods for treatment of skin discoloration

    Evera Laboratories, LLC · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7288608

    Degradable thiol-ene polymers

    The Regents of the University of Colorado · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7288657

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7288646

    USPA2 nucleic acid of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Tue Oct 30 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 25 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. AU 2007242062

    Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

    ALPHAPHARM PTY LTD [AU] · Granted Thu Nov 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. CA 2648495

    FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE

    ALPHAPHARM PTY LTD [AU] · Granted Thu Nov 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Oct 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7291603

    Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

    PTC THERAPEUTICS, INC. · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7291611

    Benzimidazolidinone derivatives as muscarinic agents

    ACADIA Pharmaceuticals Inc. · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7291614

    Processes for the preparation of linezolid intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7291348

    Compositions and methods for biodegradable microspheres as carriers of bioactive substances

    The Board of Regents of the University of Texas System · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. IT MI20070164

    CEROTTO TRANSDERMICO

    AXXONIS PHARMA AG · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7291336

    Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7291699

    Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders

    The Regents of the University of Colorado · Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7294735

    Purification of cinacalcet

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7294475

    Gene and use thereof

    Takeda Chemical Industries Ltd. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7294687

    Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7294480

    High throughput screening assays using fatty acid synthetic enzymes

    Xenon Pharmaceuticals Inc. · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7294344

    Sustained-release preparation for AII antagonist, production and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7294496

    Cloned human lysophospholipase

    The Regents of the University of California · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7294699

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Tue Nov 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7297523

    Human elongase genes and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Tue Nov 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7297488

    Identifying and testing antisense oligonucleotides that inhibit telomerase reverse transcriptase

    The Regents of the University of Colorado · Granted Tue Nov 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7300774

    Multimeric fusion proteins of the TNF superfamily ligands

    The Regents of the University of California · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7300949

    Thiazolopyrazoles and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7301024

    Crystalline forms of gatifloxacin and processes for preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2027?

599 published patents in our USPTO index have expiration dates falling in calendar year 2027.